JAK2 and lung carcinoma: Ovarian cancer EV miR-630 has been found to activate NF-κB [187] and lung cancer EV miR-210 activated the janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway [188], prompting the switch of fibroblasts to CAFs.